What Are The Chances Of Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. The stock was recently discussed on Yahoo Finance as it revealed that Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

As a NASDAQ listed company, VNDA falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Vanda Pharmaceuticals Inc is $236.49M. A total of 1.37 million shares were traded on the day, compared to an average of 974.27K shares.

In the most recent transaction, Polymeropoulos Mihael Hristos sold 24,288 shares of VNDA for 4.13 per share on Mar 05 ’24. After the transaction, the President and CEO now owns 1,871,730 company shares. In a previous transaction on Mar 05 ’24, Wijkstrom Joakim sold 9,229 shares at 4.21 per share. VNDA shares that SVP, Chief Marketing Officer owns now total 129,789.

Among the insiders who sold shares, Moran Kevin Patrick disposed of 8,902 shares on Mar 05 ’24 at a per-share price of $4.20. This resulted in the SVP, CFO & Treasurer holding 231,014 shares of VNDA after the transaction. In another insider transaction, Williams Timothy sold 8,941 shares at $4.18 per share on Mar 05 ’24. Company shares held by the SVP & General Counsel now total 196,825.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, VNDA has a high of $7.00 and a low of $3.30.

As of this writing, VNDA has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of $0.05 per share and a lower estimate of $0.05. The company reported an EPS of $0 in the last quarter, which was 100.00% higher than expectations of -$0.04.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. VNDA’s latest balance sheet shows that the firm has $432.81M in Cash & Short Term Investments as of fiscal 2021. There were $12.37M in debt and $74.42M in liabilities at the time. Its Book Value Per Share was $9.47, while its Total Shareholder’s Equity was $504.93M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VNDA is Buy with a score of 3.00.

Most Popular

Related Posts